A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors-Reference-Cited by-同舟云学术

A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors

Published:2019-10 Issue: Volume:180 Page:613-626
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Pérez-Areales F. Javier,Turcu Andreea L.,Barniol-Xicota Marta,Pont Caterina,Pivetta Deborah,Espargaró Alba,Bartolini Manuela^ORCID,De Simone Angela,Andrisano Vincenza,Pérez Belén,Sabate Raimon,Sureda Francesc X.,Vázquez Santiago^ORCID,Muñoz-Torrero Diego^ORCID

Funder

Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación (AEI)

FEDER

Generalitat de Catalunya

Ministerio de Economía y Competitividad

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference70 articles.

1. World Alzheimer Report 2015. The Global Impact of Dementia. An Analysis of Prevalence, Incidence, Cost & Trends;Prince,2015

2. Beyond symptomatic effects: potential of donepezil as a neuroprotective agent and disease modifier in Alzheimer's disease;Kim;Br. J. Pharmacol.,2017